Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Disease-modifying antirheumatic drugs are used in virtually all patients with established rheumatoid arthritis. An increasingly large number of new drugs is now available. Furthermore, old therapies are being used in novel ways. Treatment is now begun earlier and patients are rarely left untreated. This report summarises recent developments regarding the drugs currently in use and those that may be available in the near future.

Type

Journal article

Journal

The British journal of clinical practice

Publication Date

03/1994

Volume

48

Pages

82 - 86

Addresses

Department of Rheumatology, University of Birmingham.

Keywords

Humans, Arthritis, Rheumatoid, Sulfasalazine, Cyclophosphamide, Methotrexate, Azathioprine, Cyclosporine, Anti-Inflammatory Agents, Non-Steroidal, Anti-Inflammatory Agents, Treatment Outcome, Immunotherapy